SURROGATE ENDPOINTS IN CLINICAL-TRIALS - CARDIOVASCULAR-DISEASES

被引:174
|
作者
WITTES, J
LAKATOS, E
PROBSTFIELD, J
机构
关键词
D O I
10.1002/sim.4780080405
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:415 / 425
页数:11
相关论文
共 50 条
  • [1] SURROGATE ENDPOINTS IN CLINICAL-TRIALS
    FRIEDMAN, L
    YUSUF, S
    [J]. CONTROLLED CLINICAL TRIALS, 1985, 6 (03): : 222 - 222
  • [2] SURROGATE ENDPOINTS IN CLINICAL-TRIALS - CANCER
    ELLENBERG, SS
    HAMILTON, JM
    [J]. STATISTICS IN MEDICINE, 1989, 8 (04) : 405 - 413
  • [3] The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases
    Lonn, E
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (06) : 497 - 508
  • [4] SURROGATE ENDPOINTS IN CLINICAL-TRIALS - OPHTHALMOLOGIC DISORDERS
    HILLIS, A
    SEIGEL, D
    [J]. STATISTICS IN MEDICINE, 1989, 8 (04) : 427 - 430
  • [5] SURROGATE ENDPOINTS IN CLINICAL-TRIALS - DEFINITION AND OPERATIONAL CRITERIA
    PRENTICE, RL
    [J]. STATISTICS IN MEDICINE, 1989, 8 (04) : 431 - 440
  • [6] Surrogate endpoints in randomized cardiovascular clinical trials
    Domanski, Michael
    Pocock, Stuart
    Bernaud, Corine
    Borer, Jeffrey
    Geller, Nancy
    Revkin, James
    Zannad, Faiez
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 (04) : 411 - 413
  • [9] Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials
    Patel, Ravi B.
    Vaduganathan, Muthiah
    Samman-Tahhan, Ayman
    Kalogeropoulos, Andreas P.
    Georgiopoulou, Vasiliki V.
    Fonarow, Gregg C.
    Gheorghiade, Mihai
    Butler, Javed
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (11): : 1845 - 1850
  • [10] Surrogate Endpoints in Clinical Trials
    Elliott, Michael R.
    [J]. ANNUAL REVIEW OF STATISTICS AND ITS APPLICATION, 2023, 10 : 75 - 96